1-3 of 3
Lajos Gera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A preclinical pharmacodynamic analysis of CU201, a novel bradykinin antagonist, using a calcium flux assay in lung cancer cell lines

Glen J. Weiss, Karen M. Helm, Lajos Gera, Paul A. Bunn, Jr., Daniel C. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A105.
Published: 15 August 2014
View article titled, A preclinical pharmacodynamic analysis of CU201, a novel bradykinin antagonist, using a calcium flux assay in lung cancer cell lines
Journal Articles

BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis

Seong Il Seo, Lajos Gera, Haiyen E. Zhau, Wei Ping Qian, Shareen Iqbal, Nicole A. Johnson, Shumin Zhang, Majd Zayzafoon, John Stewart, Ruoxiang Wang, Leland W.K. Chung, Daqing Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19): 6198–6206.
https://doi.org/10.1158/1078-0432.CCR-08-1023
Published: 30 September 2008
View article titled, BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis
Open the PDF for BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis in another window
Journal Articles

Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines in Vitro and in Vivo and Produces Synergistic Growth Inhibition in Combination with Other Antitumor Agents

Daniel C. Chan, Lajos Gera, John M. Stewart, Barbara Helfrich, Tom Limin Zhao, Wan Yong Feng, Kenneth K. Chan, Joseph M. Covey, Paul A. Bunn, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1280–1287.
Published: 01 May 2002
View article titled, Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines <em>in Vitro</em> and <em>in Vivo</em> and Produces Synergistic Growth Inhibition in Combination with Other Antitumor Agents
Open the PDF for Bradykinin Antagonist Dimer, CU201, Inhibits the Growth of Human Lung Cancer Cell Lines <em>in Vitro</em> and <em>in Vivo</em> and Produces Synergistic Growth Inhibition in Combination with Other Antitumor Agents in another window